Compound ID | 880
Class: Quinoline-indole
| Spectrum of activity: | Gram-negative |
| Details of activity: | Potent against S. aureus |
| Institute where first reported: | Sepracor; Sunovion Pharmaceuticals, Inc |
| Year first mentioned: | 1999 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://academic.oup.com/cid/article/31/6/1423/368963 |